This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2000 Aug;32(2):436-8.

doi: 10.1053/jhep.2000.16216.

Maintenance interferon for chronic hepatitis C: more issues than answers?

PMID: 10915756
DOI: 10.1053/jhep.2000.16216

Editorial

Maintenance interferon for chronic hepatitis C: more issues than answers?

G T Everson. Hepatology. 2000 Aug.

. 2000 Aug;32(2):436-8.

doi: 10.1053/jhep.2000.16216.

Author

PMID: 10915756
DOI: 10.1053/jhep.2000.16216

No abstract available

PubMed Disclaimer

Comment in

Adjuvant interferon for hepatocellular carcinoma.
Okada S, Sato T, Yamamoto S. Okada S, et al. Hepatology. 2001 Feb;33(2):481-2. doi: 10.1002/hep.510330227. Hepatology. 2001. PMID: 11172357 No abstract available.

Comment on

Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer.
Ikeda K, Arase Y, Saitoh S, Kobayashi M, Suzuki Y, Suzuki F, Tsubota A, Chayama K, Murashima N, Kumada H. Ikeda K, et al. Hepatology. 2000 Aug;32(2):228-32. doi: 10.1053/jhep.2000.9409. Hepatology. 2000. PMID: 10915728 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information